
8.77BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US2183521028
CUSIP
218352102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
178.80
PEG Ratio
0.81
Book Value
6.54
Dividend Share
-
Dividend Yield
-
Earnings Share
0.45
Wall Street Target Price
141.00
EPS Estimate Current Year
2.12
EPS Estimate Next Year
4.20
EPS Estimate Current Quarter
0.0467
EPS Estimate Next Quarter
0.3333
Most Recent Quarter
-
Revenue TTM
830,812,992
Gross Profit TTM
816,728,000
EBITDA
8,084,000
Profit Margin
6.64%
Return On Assets TTM
0.47%
Return On Equity TTM
8.23%
Revenue Per Share TTM
7.968
Qtly Revenue Growth YOY
31.70%
Diluted Eps TTM
0.45
Qtly Earnings Growth YOY
24.10%
Trailing PE
178.80
Forward PE
14
Price Sales TTM
10.4688
Price Book MRQ
12.4245
Enterprise Value Revenue
10
Enterprise Value EBITDA
959
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%